EUVIMEDEUVIMED entdecken
Crossref

TBXT expression in development and cancer: signaling, enhancers and epigenetics

Akechai Kongprajug, Mohammad Hamza, Fiona C. Wardle

Academia Molecular Biology and Genomics · 19.11.2026 · 3 (4)

DOI: 10.20935/acadmolbiogen8651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Molecular Biology and Genomics, online erschienen am 19.11.2026. Verfasst von Akechai Kongprajug und 2 weiteren Autor:innen. Die Arbeit nennt 107 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transcription factor TBXT plays a pivotal role in vertebrate embryogenesis and has emerged as a key regulator in some cancers. During embryonic development, TBXT governs notochord differentiation and posterior body elongation, with its expression tightly controlled by signaling pathways including Nodal/Activin, bone morphogenetic protein (BMP), fibroblast growth factor (FGF), WNT, and retinoic acid (RA). These pathways act through conserved and species-specific cis-regulatory elements (CREs) that integrate activating and repressive inputs to ensure precise spatiotemporal expression. Beyond development, TBXT is aberrantly expressed in multiple cancers and functions in a context-dependent manner, acting as a driver in chordoma and promoting metastasis and poor prognosis in epithelial cancers such as triple-negative breast and non-small cell lung cancer, while exerting a protective role in glioma. Its dysregulation is influenced by signaling pathways including FGF, phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), transforming growth factor β (TGF-β), WNT, and hypoxia, and by epigenetic mechanisms. Notably, a super-enhancer downstream of TBXT drives its expression in chordoma, but the specific CREs that drive expression in other cancers remain uncharacterized. Elucidating how signaling pathways and CREs interact to regulate TBXT expression may offer avenues for targeted therapeutic interventions in cancers dependent on TBXT.

Zitieren

APA

Kongprajug, A., Hamza, M., & Wardle, F. C. (2026). TBXT expression in development and cancer: signaling, enhancers and epigenetics. Academia Molecular Biology and Genomics, 3(4). https://doi.org/10.20935/acadmolbiogen8651

Vancouver

Kongprajug A, Hamza M, Wardle FC. TBXT expression in development and cancer: signaling, enhancers and epigenetics. Academia Molecular Biology and Genomics. 2026;3(4). doi:10.20935/acadmolbiogen8651

BibTeX
@article{Kongprajug2026,
  author = {Kongprajug, Akechai and Hamza, Mohammad and Wardle, Fiona C.},
  title = {TBXT expression in development and cancer: signaling, enhancers and epigenetics},
  journal = {Academia Molecular Biology and Genomics},
  year = {2026},
  volume = {3},
  number = {4},
  doi = {10.20935/acadmolbiogen8651}
}
Kostenlos starten →